TCMBANKIN004745 |
3β,19α-dihydroxy-6-oxo-urs-12-en-23-al-28-oicacid |
|
C30H44O6 |
|
CC1CCC2(CCC3(C(=CCC4C3(CC(=O)C5C4(CCC(C5(C)C=O)O)C)C)C2C1(C)O)C)C(=O)O |
TCMBANKIN017834 |
acrifolinol |
|
C16H22O3 |
|
CC12CCC3C(CC(=O)C3=C)C4C(O4)(CCC1O2)C |
TCMBANKIN018219 |
3α-angeloyloxy-9β-hydroxy-ent-kaura-16-en-19-oic acid |
|
|
|
|
TCMBANKIN018728 |
alpha-onocerin |
(2S,4aR,5S,8aR)-5-{2-[(1S,4aR,6S,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl]ethyl}-1,1,4a-trimethyl-6-methylenedecahydronaphthalen-2-ol; MolPort-006-111-540; GESZMTVZGWZBPW-IHIDZKKCSA-; 2-Naphthalenol,5,5'-(1,2-ethanediyl)bis[decahydro-1,1,4a-trimethyl-6-methylene-,(2S,2'S,4aR,4'aR,5S,5'S,8aR,8'aR)-; 8,14-secogammacera-8(26),14(27)-diene-3beta,21alpha-diol; (3beta,21alpha)-8,14-Secogammacera-8(26),14(27)-diene-3,21-diol; ZINC38605938; alpha-Onocerol; α-onocerin; C21734; Alpha-onocerin, primary pharmaceutical reference standard; CHEBI:138303; (2S,4AR,5S,8AR)-5-{2-[(1S,4AR,6S,8AR)-6-HYDROXY-5,5,8A-TRIMETHYL-2-METHYLIDENE-HEXAHYDRO-1H-NAPHTHALEN-1-YL]ETHYL}-1,1,4A-TRIMETHYL-6-METHYLIDENE-HEXAHYDRO-2H-NAPHTHALEN-2-OL; MCULE-4277793393; EINECS 208-118-6; W2391; 511-01-3; InChI=1/C30H50O2/c1-19-9-13-23-27(3,4)25(31)15-17-29(23,7)21(19)11-12-22-20(2)10-14-24-28(5,6)26(32)16-18-30(22,24)8/h21-26,31-32H,1-2,9-18H2,3-8H3/t21-,22-,23-,24-,25-,26-,29+,30+/m0/s1; alpha-Onocerin; SC-97924; (+)-alpha-onocerin |
C30H50O2 |
442.7 g/mol |
CC1(C2CCC(=C)C(C2(CCC1O)C)CCC3C(=C)CCC4C3(CCC(C4(C)C)O)C)C |
TCMBANKIN022601 |
diterpenoid sugiol |
|
|
|
|
TCMBANKIN043172 |
26-O-(3'-Isopentanoyl)-β-D-glucopyranosyl-5α-furost-20(22)-ene-3β,26-diol |
|
|
|
|
TCMBANKIN045060 |
16-Oxolyclanitin |
|
|
|
|
TCMBANKIN047150 |
26,27-dihydroxy-lanosta-7,9(11),24-trien-3,16-dione |
(14R)-17-[(2R)-7-hydroxy-6-(hydroxymethyl)hept-5-en-2-yl]-4,4,7,10,13,14-hexamethyl-2,5,6,12,15,17-hexahydro-1H-cyclopenta[a]phenanthrene-3,16-dione; AC1NSUO4 |
C30H44O4 |
468.7 g/mol |
CC(CCC=C(CO)CO)C1C(=O)CC2(C1(CC=C3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C |
TCMBANKIN047551 |
o-acetyl-dihydrolycopodine |
|
C18H29NO2 |
|
|
TCMBANKIN048263 |
16-oxolyclanitin 30-(4-hydroxycinnamoyl) |
|
C39H54O8 |
|
|
TCMBANKIN059149 |
Ergosterol peroxide |
2061-64-5; NSC31324; Ergosterol peroxide; 5.alpha.,8.alpha.-Ergosta-6,22-dien-3.beta.-ol, 5,8-epidioxy-; ERGOSTEROL-5,8-PEROXIDE; Ergosterol 5.alpha.,8.alpha.-epidioxide; Ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3.beta.,5.alpha.,8.alpha.,22E)-; Ergosterol endoperoxide; (3β,5α,8α,22E,24R)-5,8-Epidioxyergosta-6,22-dien-3-ol; 5,8-epidioxyergosta-6,22-dien-3-ol; Peroxyergosterol; ergosterol peroxide; 2061-64-5; ergosterolperoxide; dimethyl-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl][?]ol; (3.beta.,5.alpha.,8.alpha.,22E)-5,8-Epidioxyergosta-6,22-dien-3-ol |
C28H44O3 |
428.6 g/mol |
CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C24C=CC5(C3(CCC(C5)O)C)OO4)C |
TCMBANKIN059548 |
21-episerratenediol |
|
C30H50O2 |
442.7 g/mol |
CC1(C2CCC3(CC4=CCC5C(C(CCC5(C4CCC3C2(CCC1O)C)C)O)(C)C)C)C |
TCMBANKIN060438 |
pseudoselagine |
|
C16H25NO2 |
263.37 g/mol |
CC1CC2CC(=O)C3CCCN4C3(C1)C2(CCC4)O |